MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by HalifaxNovaScoton Jul 01, 2020 9:08am

309 Views

Post# 31211709

Medmira's REVEAL COVID-19 Total Antibody Testing

Medmira's REVEALCOVID-19 Total Antibody Testing would be invaluable with regards to Covid-19.

Almost instant detection.

Think of its limitless uses: schools and universities, churches, businesses (including retail and restaurants and offices), hospitals, military. The list, as I say, is limitless.

Being a Medmira shareholder makes me exceedingly proud that I own shares of a company that could very well help the health of others in this uncertain world.

Happy CANADA DAY!

https://medmira.com

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading